These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2860592)

  • 21. Opioids modulate post-ischemic progression in a rat model of stroke.
    Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
    Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes.
    Ni X; Lin BC; Song CY; Wang CH
    Neuropeptides; 1999 Apr; 33(2):137-43. PubMed ID: 10657483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peculiarities of ischemic cardiac arrhythmias in cats against the background of stimulation of sensorimotor cortex and administration of selective opiate receptor agonists.
    Mikhailova SD; Glushchenko NV; Semushkina TM; Storozhakov GI
    Bull Exp Biol Med; 2000 May; 129(5):423-4. PubMed ID: 10977939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone.
    Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F
    J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New and experimental therapeutic roles for naloxone and related opioid antagonists.
    McNicholas LF; Martin WR
    Drugs; 1984 Jan; 27(1):81-93. PubMed ID: 6319107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contribution of endogenous opioids to myocardial ischemic tolerance.
    Romano MA; Seymour EM; Berry JA; McNish RA; Bolling SF
    J Surg Res; 2004 May; 118(1):32-7. PubMed ID: 15093714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus.
    Mazarati A; Liu H; Wasterlain C
    Neuroscience; 1999 Mar; 89(1):167-73. PubMed ID: 10051226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.
    Dixon DM; Traynor JR
    Br J Pharmacol; 1990 Nov; 101(3):674-8. PubMed ID: 1981690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous opioids may mediate secondary damage after experimental brain injury.
    McIntosh TK; Hayes RL; DeWitt DS; Agura V; Faden AI
    Am J Physiol; 1987 Nov; 253(5 Pt 1):E565-74. PubMed ID: 2891303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid antagonists for smoking cessation.
    David S; Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2001; (3):CD003086. PubMed ID: 11687036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levallorphan and dynorphin improve motor dysfunction in Mongolian gerbils with unilateral carotid occlusion: the first application of the inclined plane method in the experimental cerebral ischemia.
    Handa N; Matsumoto M; Kitagawa K; Uehara A; Ogawa S; Etani H; Yoneda S; Kimura K; Kamada T
    Life Sci; 1988; 42(19):1825-31. PubMed ID: 2897055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
    Xue JC; Yu YX; Han JS; Jen MF
    Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats.
    Hölter SM; Spanagel R
    Psychopharmacology (Berl); 1999 Aug; 145(4):360-9. PubMed ID: 10460312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynorphin reduces calcium-dependent action potential duration by decreasing voltage-dependent calcium conductance.
    Werz MA; Macdonald RL
    Neurosci Lett; 1984 May; 46(2):185-90. PubMed ID: 6146120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.